市場調査レポート
商品コード
1091558

in vitro毒性試験の世界市場:製品(アッセイ(ウェスタンブロット、組織培養)、装置、消耗品、ソフトウェア)、毒性エンドポイント(ADME、皮膚刺激、細胞毒性)、技術、手法、業界(製薬、バイオテクノロジー)別 - 2027年までの予測

In Vitro Toxicology Testing Market by Product (Assays (Western Blot, Tissue Culture), Equipment, Consumables, Software), Toxicity Endpoints (ADME, Skin Irritation, Cytotoxicity), Technology, Method, Industry (Pharma,Biotech) - Global Forecast to 2027

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 356 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.29円
in vitro毒性試験の世界市場:製品(アッセイ(ウェスタンブロット、組織培養)、装置、消耗品、ソフトウェア)、毒性エンドポイント(ADME、皮膚刺激、細胞毒性)、技術、手法、業界(製薬、バイオテクノロジー)別 - 2027年までの予測
出版日: 2022年06月09日
発行: MarketsandMarkets
ページ情報: 英文 356 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のin vitro毒性試験の市場規模は、2022年の112億米ドルから、10.8%のCAGRで推移し、2027年までに186億米ドルに達すると予測されています。

技術の進歩、医薬品開発の初期段階における毒性検出の研究開発費増加などが、市場を牽引する要因となっています。

地域別では、欧州が2021年の世界市場で最大のシェアを占めています。同地域の化学および化粧品産業におけるin vitro毒性試験アッセイおよびサービスの高い採用率などが、同市場成長の要因となっています。

当レポートでは、世界のin vitro毒性試験市場について調査し、市場力学、セグメント・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 市場の促進要因
    • 市場の抑制要因
    • 市場の機会
    • 市場の課題

第6章 業界考察

  • 業界の動向
  • サプライチェーン分析
  • 規制委員会の活動
  • COVID-19のinvitro毒性市場への影響
  • ポーターのファイブフォース分析
  • 技術分析

第7章 in vitro毒性試験市場:製品・サービス別

  • COVID-19の影響
  • 消耗品
  • アッセイ
    • 細菌毒性アッセイ
    • 酵素毒性アッセイ
    • 細胞ベースのELISAおよびウエスタンブロット
    • 受容体結合アッセイ
    • 組織培養アッセイ
    • その他
  • 装置
  • ソフトウェア
  • サービス

第8章 in vitro毒性試験市場:毒性エンドポイントおよび試験別

  • ADME(吸収・分布・代謝・排泄)
  • 皮膚の刺激・腐食・感作
  • 遺伝子毒性
  • 細胞毒性
  • 眼毒性試験
  • 臓器毒性
  • 光毒性
  • 皮膚毒性
  • その他

第9章 in vitro毒性試験市場:技術別

  • 細胞培養
  • ハイスループット
  • 毒性ゲノム

第10章 in vitro毒性試験市場:業界別

  • COVID-19の影響
  • 医薬品・バイオ医薬品
  • 化粧品・家庭用品
  • 食物
  • 化学薬品

第11章 in vitro毒性試験市場:手法別

  • 細胞アッセイ
  • 生化学的アッセイ
  • in silicoモデル
  • ex-vivoモデル

第12章 in vitro毒性試験市場:地域別

  • COVID-19の影響、地域別
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他
  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他
  • ラテンアメリカ
  • 中東・アフリカ

第13章 競合情勢

  • 概要
  • 主要企業の戦略/有力企業
  • 市場シェア分析
  • 主要市場参入企業の収益シェア分析
  • 企業評価クアドラント
  • 企業評価クアドラント:スタートアップ/中小企業
  • 企業のフットプリント分析
  • 企業の地域のフットプリント
  • スタートアップ/中小企業の競合ベンチマーク
  • 競合シナリオ

第14章 企業プロファイル

  • 主要企業
    • THERMO FISHER SCIENTIFIC, INC.
    • MERCK KGAA
    • EUROFINS SCIENTIFIC SE
    • GENERAL ELECTRIC COMPANY
    • LABORATORY CORPORATION OF AMERICA HOLDINGS
    • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
    • SGS SA
    • BIO-RAD LABORATORIES, INC.
    • QIAGEN
    • EVOTEC AG
    • PROMEGA CORPORATION
    • CATALENT, INC.
  • その他の企業
    • GENTRONIX LIMITED
    • MB RESEARCH LABORATORIES
    • BIOIVT
    • CREATIVE BIOLABS
    • GVK BIOSCIENCES PRIVATE LIMITED
    • SHANGHAI MEDICILON INC.
    • CREATIVE BIOARRAY
    • INSPHERO

第15章 関連市場

  • in vivo毒性市場
  • in vivo毒性市場:製品別
  • in vivo毒性市場:毒性エンドポイント別
  • in vivo毒性市場:地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ

第16章 付録

目次
Product Code: BT 2373

The in vitro toxicology testing market is expected to reach USD 18.6 billion by 2027 from an estimated USD 11.2 billion in 2022, at a CAGR of 10.8%. Factors such as, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the factors to drive the market

"The ADME segment is expected to account for the largest market share in 2021."

Based on toxicity endpoints and tests undertaken across all industries, the in vitro toxicity testing market is segmented into genotoxicity; cytotoxicity; ADME; skin irritation, corrosion, & sensitization; ocular toxicity; organ toxicity; phototoxicity; dermal toxicity; and other endpoints & tests. In 2021, the ADME segment accounted for the largest share of the in vitro toxicity testing market.

"During the forecast period, the software segment is expected to grow at the highest rate."

On the basis of product and service, the in vitro toxicology testing market is segmented into consumables, assays, equipment, software, and services. Due to the increasing use of softwares in industry, the software segment is projected to witness the highest growth in the in vitro toxicology testing market during the forecast period.

"During the forecast period, toxicogenomics is expected to grow at the highest rate."

During the forecast period, the toxicogenomics segment is expected to grow at the highest CAGR, due to the technological advancements taking place in the field of genomics and proteomics.

"In 2021, Europe is expected to hold the largest share for players operating in the in vitro toxicology testing market."

In 2021, Europe accounted for the largest share of the in vitro toxicology testing market. Factors such as high adoption of in vitro toxicology testing assays and services in the chemical and cosmetics industries in the region are among the primary reasons expected to contribute to the growth of this market.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
  • By Designation: C-level (35%), Director-level (25%), and Others (40%)
  • By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%), and the Middle East & Africa (2%)

Key players in the In Vito Toxiocology Testing Market

The prominent players in the in vitro toxicology testing market include Thermo Fisher Scientific Inc. (US), Laboratory Corporation of America Holdings (US), Bio-Rad Laboratories, Inc. (US), General Electric Company (US), Eurofins Scientific (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Evotec (UK), SGS S.A. (Switzerland), QIAGEN (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), MB Research Laboratories (US) ,Creative Biolabs(US), GVK Biosciences Private Limited (India), Shanghai Medicon Inc (China), Creative Biorray (US) and Insphero (Switzerland).

Research Coverage:

The report aims at estimating the market size and future growth potential of the global in vitro toxicology testing market and its product & service, technology, toxicity endpoint & test, industry, method, and regional segments. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global in vitro toxicology testing market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global in vitro toxicology testing market
  • Market Development: Comprehensive information on the lucrative emerging regions
  • Market Diversification: Exhaustive information about the new product, growing geographies, and recent developments in the global in vitro toxicology testing market
  • Competitive Assessment: In-depth assessment of market ranking, growth strategies, revenue analysis, and services of leading players in the global in vitro toxicology testing market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 IN VITRO TOXICOLOGY TESTING MARKET
    • FIGURE 2 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC SCOPE
    • 1.2.3 YEARS CONSIDERED FOR STUDY
  • 1.3 CURRENCY
  • 1.4 STAKEHOLDERS
  • 1.5 LIMITATIONS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 3 RESEARCH DESIGN
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primaries
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION & VALIDATION APPROACH
    • FIGURE 5 MARKET SIZE APPROACH
    • FIGURE 6 BOTTOM-UP APPROACH
  • 2.3 DATA TRIANGULATION APPROACH
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 ASSUMPTIONS FOR STUDY

3 EXECUTIVE SUMMARY

    • FIGURE 8 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 9 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2022 VS. 2027 (USD MILLION)
    • FIGURE 10 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
    • FIGURE 11 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022 VS. 2027 (USD MILLION)
    • FIGURE 12 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022 VS. 2027 (USD MILLION)
    • FIGURE 13 GEOGRAPHIC ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET

4 PREMIUM INSIGHTS

  • 4.1 IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW
    • FIGURE 14 OPPOSITION TO ANIMAL TESTING IS MAJOR FACTOR DRIVING MARKET GROWTH
  • 4.2 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD
    • FIGURE 15 CELLULAR ASSAYS HELD LARGEST SHARE OF IN VITRO TOXICOLOGY TESTING MARKET IN ASIA PACIFIC IN 2021
  • 4.3 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 16 CHINA IS LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL IN VITRO TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD
  • 4.4 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION
    • FIGURE 17 EUROPE WILL CONTINUE TO DOMINATE IN VITRO TOXICOLOGY TESTING MARKET IN 2027
  • 4.5 IN VITRO TOXICOLOGY TESTING MARKET: DEVELOPED VS. DEVELOPING MARKETS
    • FIGURE 18 DEVELOPING MARKETS TO REGISTER HIGHER CAGR THAN DEVELOPED MARKETS THROUGHOUT FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Public opposition to animal testing
      • 5.2.1.2 Technological advancements in toxicology
      • 5.2.1.3 R&D on early-stage toxicity detection
    • 5.2.2 MARKET RESTRAINTS
      • 5.2.2.1 Reluctance of some regulatory authorities to adopt alternative toxicology testing methods
      • 5.2.2.2 Failure to establish intricacies of in-vivo conditions
      • 5.2.2.3 Lack of in vitro models to study complex endpoints
    • 5.2.3 MARKET OPPORTUNITIES
      • 5.2.3.1 Growing focus on drug discovery and personalized medicine using in vitro methods
      • 5.2.3.2 Increasing number of toxicology databases
    • 5.2.4 MARKET CHALLENGES
      • 5.2.4.1 Dearth of skilled professionals in toxicity testing

6 INDUSTRY INSIGHTS

  • 6.1 INTRODUCTION
  • 6.2 INDUSTRY TRENDS
    • 6.2.1 INCREASING FOCUS ON PREDICTIVE TOXICOLOGY
  • 6.3 SUPPLY CHAIN ANALYSIS
    • FIGURE 20 SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
  • 6.4 REGULATORY COMMITTEE ACTIVITIES
    • 6.4.1 MAJOR STAKEHOLDERS
    • 6.4.2 KEY INFLUENCERS
  • 6.5 COVID-19 IMPACT ON IN VITRO TOXICOLOGY MARKET
    • FIGURE 21 IMPACT OF COVID-19 ON IN VITRO TOXICOLOGY TESTING MARKET
  • 6.6 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 1 PORTER'S FIVE FORCES ANALYSIS
    • 6.6.1 THREAT OF NEW ENTRANTS
    • 6.6.2 THREAT OF SUBSTITUTES
    • 6.6.3 BARGAINING POWER OF SUPPLIERS
    • 6.6.4 DEGREE OF COMPETITIVE RIVALRY
  • 6.7 TECHNOLOGY ANALYSIS

7 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE

  • 7.1 INTRODUCTION
  • 7.2 COVID-19 IMPACT, BY PRODUCT & SERVICE
    • FIGURE 22 CONSUMABLES TO CAPTURE MAJORITY OF MARKET SHARE IN 2022
    • TABLE 2 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2021 (USD MILLION)
    • TABLE 3 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022-2027 (USD MILLION)
  • 7.3 CONSUMABLES
    • 7.3.1 CONSUMABLES TO ACCOUNT FOR LARGER MARKET SHARE THAN OTHER PRODUCTS IN 2022
    • TABLE 4 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 5 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 7.4 ASSAYS
    • TABLE 6 ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY TYPE, 2019-2021 (USD MILLION)
    • TABLE 7 ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 8 ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 9 ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
    • 7.4.1 BACTERIAL TOXICITY ASSAYS
      • 7.4.1.1 Bacterial assays to capture largest market share in coming years owing to their increasing adoption across several industries
    • TABLE 10 BACTERIAL TOXICITY ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 11 BACTERIAL TOXICITY ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
    • 7.4.2 ENZYME TOXICITY ASSAYS
      • 7.4.2.1 Enzyme toxicity assays are increasingly used in endocrine-disrupting studies-major factor driving market growth
    • TABLE 12 ENZYME TOXICITY ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 13 ENZYME TOXICITY ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
    • 7.4.3 CELL-BASED ELISA & WESTERN BLOTS
      • 7.4.3.1 Cell-based assays are cost-effective, thereby witnessing increasing adoption in drug discovery
    • TABLE 14 CELL-BASED ELISA & WESTERN BLOTS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 15 CELL-BASED ELISA & WESTERN BLOTS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
    • 7.4.4 RECEPTOR-BINDING ASSAYS
      • 7.4.4.1 Receptor-binding assays are suitable for high-throughput formats, thereby exhibiting accelerated demand
    • TABLE 16 RECEPTOR-BINDING ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 17 RECEPTOR-BINDING ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
    • 7.4.5 TISSUE CULTURE ASSAYS
      • 7.4.5.1 Tissue culture assays can mimic in-vivo tissue architecture, thereby attracting researchers
    • TABLE 18 TISSUE CULTURE ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 19 TISSUE CULTURE ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
    • 7.4.6 OTHER ASSAYS
    • TABLE 20 OTHER ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 21 OTHER ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 7.5 EQUIPMENT
    • 7.5.1 FULLY AUTOMATED IN VITRO TOXICOLOGY EQUIPMENT ARE INCREASINGLY ADOPTED IN RESEARCH
    • TABLE 22 EQUIPMENT: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 23 EQUIPMENT: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 7.6 SOFTWARE
    • 7.6.1 SOFTWARE SOLUTIONS ARE VITAL IN REDUCING ANALYSIS TIME AND MANAGING LARGE VOLUMES OF DATA GENERATED DURING OPERATIONS
    • TABLE 24 SOFTWARE: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 25 SOFTWARE: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 7.7 SERVICES
    • 7.7.1 LACK OF INFRASTRUCTURE AND EXPERTISE HAVE DRIVEN RELIANCE ON SERVICE PROVIDERS
    • TABLE 26 SERVICES: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 27 SERVICES: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)

8 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST

  • 8.1 INTRODUCTION
    • FIGURE 23 ORGAN TOXICITY TESTING TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
    • TABLE 28 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019-2021 (USD MILLION)
    • TABLE 29 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2022-2027 (USD MILLION)
  • 8.2 ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION)
    • 8.2.1 ADME TESTING TO COMMAND IN VITRO TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD
    • TABLE 30 ADME: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 31 ADME: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 8.3 SKIN IRRITATION, CORROSION, & SENSITIZATION
    • 8.3.1 SKIN IRRITATION, CORROSION, & SENSITIZATION ARE MAJOR ENDPOINTS STUDIED IN COSMETICS INDUSTRY
    • TABLE 32 SKIN IRRITATION, CORROSION, & SENSITIZATION: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 33 SKIN IRRITATION, CORROSION, & SENSITIZATION: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 8.4 GENOTOXICITY
    • 8.4.1 REGULATORY AUTHORITIES REVIEW AND VALIDATE HIGHER NUMBER OF GENOTOXICITY TESTS THAN ANY OTHER ENDPOINT, THEREBY PROPELLING MARKET GROWTH
    • TABLE 34 GENOTOXICITY: IN VITRO TOXICOLOGY TESTING, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 35 GENOTOXICITY: IN VITRO TOXICOLOGY TESTING, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 8.5 CYTOTOXICITY
    • 8.5.1 RISING NEED FOR BIOSAFETY LARGELY CONTRIBUTES TO GROWTH OF CYTOTOXICITY TESTING MARKET
    • TABLE 36 CYTOTOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 37 CYTOTOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 8.6 OCULAR TOXICITY TESTING
    • 8.6.1 IN VITRO AND EX-VIVO METHODS ARE GAINING HIGH RECOGNITION FOR OCULAR TOXICITY TESTING
    • TABLE 38 OCULAR TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 39 OCULAR TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 8.7 ORGAN TOXICITY
    • 8.7.1 HIGH-CONTENT SCREENING AND CELL-BASED ASSAYS ARE USED TO DETECT ORGAN-SPECIFIC TOXICITY
    • TABLE 40 ORGAN TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 41 ORGAN TOXICITY: TE IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 8.8 PHOTOTOXICITY
    • 8.8.1 VALIDATED NON-ANIMAL METHODS ARE USED TO EVALUATE PHOTO SAFETY OF COSMETICS, PHARMACEUTICALS, & CHEMICALS
    • TABLE 42 PHOTOTOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 43 PHOTOTOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 8.9 DERMAL TOXICITY
    • 8.9.1 IN VITRO METHODS FOR DERMAL TOXICITY TESTING ARE EXPECTED TO GAIN RECOGNITION IN COMING YEARS
    • TABLE 44 DERMAL TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 45 DERMAL TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 8.10 OTHER ENDPOINTS & TESTS
    • TABLE 46 OTHER ENDPOINTS & TESTS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 47 OTHER ENDPOINTS & TESTS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)

9 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY

  • 9.1 INTRODUCTION
    • FIGURE 24 TOXICOGENOMICS SEGMENT TO EXHIBIT HIGHEST CAGR IN IN VITRO TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD
    • TABLE 48 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2021 (USD MILLION)
    • TABLE 49 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022-2027 (USD MILLION)
  • 9.2 CELL CULTURE
    • 9.2.1 CELL- & TISSUE-BASED TECHNOLOGIES ARE WIDELY ADOPTED IN IN VITRO TESTING
    • TABLE 50 CELL CULTURE: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 51 CELL CULTURE: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 9.3 HIGH-THROUGHPUT
    • 9.3.1 INCREASING USE OF HIGH-CONTENT IMAGING TECHNOLOGIES IN TOXICITY TESTING BOOSTS MARKET GROWTH
    • TABLE 52 HIGH-THROUGHPUT: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 53 HIGH-THROUGHPUT: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 9.4 TOXICOGENOMICS
    • 9.4.1 IMPROVEMENTS IN PROTEOMIC TECHNOLOGIES ENHANCE STUDY OF GENES & PROTEIN ACTIVITIES DURING TOXICITY ANALYSIS
    • TABLE 54 TOXICOGENOMICS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 55 TOXICOGENOMICS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)

10 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY

  • 10.1 INTRODUCTION
    • FIGURE 25 PHARMACEUTICALS & BIOPHARMACEUTICALS INDUSTRY TO HOLD LARGEST MARKET SHARE THROUGHOUT FORECAST PERIOD
    • TABLE 56 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2021 (USD MILLION)
    • TABLE 57 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022-2027 (USD MILLION)
  • 10.2 COVID-19 IMPACT, BY INDUSTRY
  • 10.3 PHARMACEUTICALS & BIOPHARMACEUTICALS
    • 10.3.1 DRUG ATTRITION RATE LEADS TO HIGH ADOPTION OF IN VITRO TESTING ASSAYS IN EARLY STAGES OF DRUG DEVELOPMENT
    • TABLE 58 PHARMACEUTICALS & BIOPHARMACEUTICALS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 59 PHARMACEUTICALS & BIOPHARMACEUTICALS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 10.4 COSMETICS & HOUSEHOLD PRODUCTS
    • 10.4.1 BAN ON ANIMAL TESTING LEADING TO ADOPTION OF IN VITRO ASSAYS FOR SAFETY TESTING
    • TABLE 60 COSMETICS & HOUSEHOLD PRODUCTS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 61 COSMETICS & HOUSEHOLD PRODUCTS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 10.5 FOOD
    • 10.5.1 INCREASING FOCUS ON FOOD SAFETY DRIVES REQUIREMENT FOR IN VITRO TOXICOLOGY TESTING PRODUCTS
    • TABLE 62 TYPES OF TOXICOLOGY TESTS IN FOOD
    • TABLE 63 FOOD: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 64 FOOD: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 10.6 CHEMICALS
    • 10.6.1 INCREASING FOCUS ON ORGANOID-BASED IN VITRO APPROACHES FOR CHEMICALS TESTING PROPELS MARKET GROWTH
    • TABLE 65 CHEMICALS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 66 CHEMICALS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)

11 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD

  • 11.1 INTRODUCTION
    • FIGURE 26 IN-SILICO MODELS TO RECORD HIGHEST CAGR IN IN VITRO TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD
    • TABLE 67 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2021 (USD MILLION)
    • TABLE 68 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022-2027 (USD MILLION)
  • 11.2 CELLULAR ASSAYS
    • 11.2.1 DEVELOPMENT OF MULTI-PARAMETER ASSAYS WILL PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES TO MARKET PLAYERS
    • TABLE 69 CELLULAR ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 70 CELLULAR ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 11.3 BIOCHEMICAL ASSAYS
    • 11.3.1 BIOCHEMICAL ASSAYS ARE ADOPTED AT HIGHER RATE IN PHARMACEUTICALS INDUSTRY THAN CHEMICALS AND FOOD INDUSTRIES
    • TABLE 71 BIOCHEMICAL ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 72 BIOCHEMICAL ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 11.4 IN-SILICO MODELS
    • 11.4.1 IN-SILICO MODELS ARE EXPECTED TO WITNESS HIGHEST CAGR FROM 2022 TO 2027
    • TABLE 73 IN-SILICO MODELS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 74 IN-SILICO MODELS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)
  • 11.5 EX-VIVO MODELS
    • 11.5.1 EX-VIVO MODELS ARE WIDELY USED IN SKIN AND EYE TOXICOLOGY TESTING IN COSMETICS INDUSTRY
    • TABLE 75 EX-VIVO MODELS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019-2021 (USD MILLION)
    • TABLE 76 EX-VIVO MODELS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022-2027 (USD MILLION)

12 IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHIC ANALYSIS

  • 12.1 INTRODUCTION
  • 12.2 COVID-19 IMPACT, BY REGION
    • FIGURE 27 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC SNAPSHOT
    • TABLE 77 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2019-2021 (USD MILLION)
    • TABLE 78 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2022-2027 (USD MILLION)
  • 12.3 EUROPE
    • FIGURE 28 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
    • TABLE 79 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2019-2021 (USD MILLION)
    • TABLE 80 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2022-2027 (USD MILLION)
    • TABLE 81 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2021 (USD MILLION)
    • TABLE 82 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022-2027 (USD MILLION)
    • TABLE 83 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019-2021 (USD MILLION)
    • TABLE 84 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 85 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019-2021 (USD MILLION)
    • TABLE 86 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022-2027 (USD MILLION)
    • TABLE 87 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2021 (USD MILLION)
    • TABLE 88 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022-2027 (USD MILLION)
    • TABLE 89 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2021 (USD MILLION)
    • TABLE 90 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022-2027 (USD MILLION)
    • TABLE 91 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2021 (USD MILLION)
    • TABLE 92 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022-2027 (USD MILLION)
    • 12.3.1 GERMANY
      • 12.3.1.1 Germany holds the largest share of the European market
    • TABLE 93 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2021 (USD MILLION)
    • TABLE 94 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022-2027 (USD MILLION)
    • TABLE 95 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019-2021 (USD MILLION)
    • TABLE 96 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 97 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019-2021 (USD MILLION)
    • TABLE 98 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022-2027 (USD MILLION)
    • TABLE 99 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2021 (USD MILLION)
    • TABLE 100 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022-2027 (USD MILLION)
    • TABLE 101 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2021 (USD MILLION)
    • TABLE 102 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022-2027 (USD MILLION)
    • TABLE 103 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2021 (USD MILLION)
    • TABLE 104 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022-2027 (USD MILLION)
    • 12.3.2 UK
      • 12.3.2.1 Rising awareness, growing R&D, and increasing collaborations for In Vitro Toxicology Testing Market are key indicators of market growth in UK
    • TABLE 105 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2021 (USD MILLION)
    • TABLE 106 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022-2027 (USD MILLION)
    • TABLE 107 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019-2021 (USD MILLION)
    • TABLE 108 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 109 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019-2021 (USD MILLION)
    • TABLE 110 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022-2027 (USD MILLION)
    • TABLE 111 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2021 (USD MILLION)
    • TABLE 112 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022-2027 (USD MILLION)
    • TABLE 113 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2021 (USD MILLION)
    • TABLE 114 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022-2027 (USD MILLION)
    • TABLE 115 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2021 (USD MILLION)
    • TABLE 116 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022-2027 (USD MILLION)
    • 12.3.3 FRANCE
      • 12.3.3.1 Proteomics research initiatives supported by government aid market growth in France
    • TABLE 117 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2021 (USD MILLION)
    • TABLE 118 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022-2027 (USD MILLION)
    • TABLE 119 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019-2021 (USD MILLION)
    • TABLE 120 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 121 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019-2021 (USD MILLION)
    • TABLE 122 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022-2027 (USD MILLION)
    • TABLE 123 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2021 (USD MILLION)
    • TABLE 124 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022-2027 (USD MILLION)
    • TABLE 125 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2021 (USD MILLION)
    • TABLE 126 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022-2027 (USD MILLION)
    • TABLE 127 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2021 (USD MILLION)
    • TABLE 128 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022-2027 (USD MILLION)
    • 12.3.4 ITALY
      • 12.3.4.1 Italian market growth is mainly driven by increased volume of life sciences research
    • TABLE 129 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2021 (USD MILLION)
    • TABLE 130 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022-2027 (USD MILLION)
    • TABLE 131 ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019-2021 (USD MILLION)
    • TABLE 132 ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 133 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019-2021 (USD MILLION)
    • TABLE 134 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022-2027 (USD MILLION)
    • TABLE 135 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2021 (USD MILLION)
    • TABLE 136 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022-2027 (USD MILLION)
    • TABLE 137 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2021 (USD MILLION)
    • TABLE 138 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022-2027 (USD MILLION)
    • TABLE 139 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2021 (USD MILLION)
    • TABLE 140 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022-2027 (USD MILLION)
    • 12.3.5 SPAIN
      • 12.3.5.1 Spain's growing Chemicals industry stimulates in vitro toxicology testing market growth
    • TABLE 141 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2021 (USD MILLION)
    • TABLE 142 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022-2027 (USD MILLION)
    • TABLE 143 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019-2021 (USD MILLION)
    • TABLE 144 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 145 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019-2021 (USD MILLION)
    • TABLE 146 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022-2027 (USD MILLION)
    • TABLE 147 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2021 (USD MILLION)
    • TABLE 148 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022-2027 (USD MILLION)
    • TABLE 149 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2021 (USD MILLION)
    • TABLE 150 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022-2027 (USD MILLION)
    • TABLE 151 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2021 (USD MILLION)
    • TABLE 152 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022-2027 (USD MILLION)
    • 12.3.6 REST OF EUROPE
    • TABLE 153 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2021 (USD MILLION)
    • TABLE 154 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022-2027 (USD MILLION)
    • TABLE 155 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019-2021 (USD MILLION)
    • TABLE 156 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 157 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019-2021 (USD MILLION)
    • TABLE 158 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022-2027 (USD MILLION)
    • TABLE 159 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2021 (USD MILLION)
    • TABLE 160 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022-2027 (USD MILLION)
    • TABLE 161 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2021 (USD MILLION)
    • TABLE 162 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022-2027 (USD MILLION)
    • TABLE 163 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2021 (USD MILLION)
    • TABLE 164 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022-2027 (USD MILLION)
  • 12.4 NORTH AMERICA
    • FIGURE 29 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
    • TABLE 165 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2019-2021 (USD MILLION)
    • TABLE 166 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2022-2027 (USD MILLION)
    • TABLE 167 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2021 (USD MILLION)
    • TABLE 168 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022-2027 (USD MILLION)
    • TABLE 169 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019-2021 (USD MILLION)
    • TABLE 170 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 171 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019-2021 (USD MILLION)
    • TABLE 172 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022-2027 (USD MILLION)
    • TABLE 173 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2021 (USD MILLION)
    • TABLE 174 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022-2027 (USD MILLION)
    • TABLE 175 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2021 (USD MILLION)
    • TABLE 176 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022-2027 (USD MILLION)
    • TABLE 177 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2021 (USD MILLION)
    • TABLE 178 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022-2027 (USD MILLION)
    • 12.4.1 US
      • 12.4.1.1 US dominates North American market due to growing focus on biomarker discovery and research in structure-based drug design
    • TABLE 179 US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2021 (USD MILLION)
    • TABLE 180 US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022-2027 (USD MILLION)
    • TABLE 181 US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019-2021 (USD MILLION)
    • TABLE 182 US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 183 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019-2021 (USD MILLION)
    • TABLE 184 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022-2027 (USD MILLION)
    • TABLE 185 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2021 (USD MILLION)
    • TABLE 186 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022-2027 (USD MILLION)
    • TABLE 187 US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2021 (USD MILLION)
    • TABLE 188 US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022-2027 (USD MILLION)
    • TABLE 189 US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2021 (USD MILLION)
    • TABLE 190 US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022-2027 (USD MILLION)
    • 12.4.2 CANADA
      • 12.4.2.1 Strong support to carry out R&D in pharmaceutical and proteomics fields fosters market growth in Canada
    • TABLE 191 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2021 (USD MILLION)
    • TABLE 192 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022-2027 (USD MILLION)
    • TABLE 193 CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019-2021 (USD MILLION)
    • TABLE 194 CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 195 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019-2021 (USD MILLION)
    • TABLE 196 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022-2027 (USD MILLION)
    • TABLE 197 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2021 (USD MILLION)
    • TABLE 198 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022-2027 (USD MILLION)
    • TABLE 199 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2021 (USD MILLION)
    • TABLE 200 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022-2027 (USD MILLION)
    • TABLE 201 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2021 (USD MILLION)
    • TABLE 202 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022-2027 (USD MILLION)
  • 12.5 ASIA PACIFIC
    • FIGURE 30 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
    • TABLE 203 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2019-2021 (USD MILLION)
    • TABLE 204 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2022-2027 (USD MILLION)
    • TABLE 205 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2021 (USD MILLION)
    • TABLE 206 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022-2027 (USD MILLION)
    • TABLE 207 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019-2021 (USD MILLION)
    • TABLE 208 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 209 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019-2021 (USD MILLION)
    • TABLE 210 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022-2027 (USD MILLION)
    • TABLE 211 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2021 (USD MILLION)
    • TABLE 212 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022-2027 (USD MILLION)
    • TABLE 213 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2021 (USD MILLION)
    • TABLE 214 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022-2027 (USD MILLION)
    • TABLE 215 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2021 (USD MILLION)
    • TABLE 216 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022-2027 (USD MILLION)
    • 12.5.1 CHINA
      • 12.5.1.1 Increasing international pressure to ban animal testing methods will propel market growth in coming years
    • TABLE 217 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2021 (USD MILLION)
    • TABLE 218 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022-2027 (USD MILLION)
    • TABLE 219 CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019-2021 (USD MILLION)
    • TABLE 220 CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 221 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019-2021 (USD MILLION)
    • TABLE 222 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022-2027 (USD MILLION)
    • TABLE 223 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2021 (USD MILLION)
    • TABLE 224 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022-2027 (USD MILLION)
    • TABLE 225 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2021 (USD MILLION)
    • TABLE 226 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022-2027 (USD MILLION)
    • TABLE 227 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2021 (USD MILLION)
    • TABLE 228 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022-2027 (USD MILLION)
    • 12.5.2 JAPAN
      • 12.5.2.1 Use of artificial skin patches and plates of cultured human cells has increased demand for in vitro toxicology testing products in Japan
    • TABLE 229 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2021 (USD MILLION)
    • TABLE 230 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022-2027 (USD MILLION)
    • TABLE 231 JAPAN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019-2021 (USD MILLION)
    • TABLE 232 JAPAN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 233 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019-2021 (USD MILLION)
    • TABLE 234 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022-2027 (USD MILLION)
    • TABLE 235 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2021 (USD MILLION)
    • TABLE 236 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022-2027 (USD MILLION)
    • TABLE 237 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2021 (USD MILLION)
    • TABLE 238 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022-2027 (USD MILLION)
    • TABLE 239 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2021 (USD MILLION)
    • TABLE 240 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022-2027 (USD MILLION)
    • 12.5.3 INDIA
      • 12.5.3.1 Growing focus of universities on avoiding use of animals to test cosmetic products is likely to propel market growth
    • TABLE 241 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2021 (USD MILLION)
    • TABLE 242 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022-2027 (USD MILLION)
    • TABLE 243 INDIA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019-2021 (USD MILLION)
    • TABLE 244 INDIA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 245 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019-2021 (USD MILLION)
    • TABLE 246 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022-2027 (USD MILLION)
    • TABLE 247 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2021 (USD MILLION)
    • TABLE 248 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022-2027 (USD MILLION)
    • TABLE 249 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2021 (USD MILLION)
    • TABLE 250 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022-2027 (USD MILLION)
    • TABLE 251 INDIA: IN VITRO TRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2021 (USD MILLION)
    • TABLE 252 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022-2027 (USD MILLION)
    • 12.5.4 REST OF ASIA PACIFIC
    • TABLE 253 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2021 (USD MILLION)
    • TABLE 254 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022-2027 (USD MILLION)
    • TABLE 255 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019-2021 (USD MILLION)
    • TABLE 256 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 257 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019-2021 (USD MILLION)
    • TABLE 258 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022-2027 (USD MILLION)
    • TABLE 259 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2021 (USD MILLION)
    • TABLE 260 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022-2027 (USD MILLION)
    • TABLE 261 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2021 (USD MILLION)
    • TABLE 262 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022-2027 (USD MILLION)
    • TABLE 263 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2021 (USD MILLION)
    • TABLE 264 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022-2027 (USD MILLION)
  • 12.6 LATIN AMERICA
    • 12.6.1 LOW COST OF DRUG TRIALS HAVE MADE LATIN AMERICA POPULAR OUTSOURCING MARKET
    • TABLE 265 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2021 (USD MILLION)
    • TABLE 266 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022-2027 (USD MILLION)
    • TABLE 267 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019-2021 (USD MILLION)
    • TABLE 268 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 269 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019-2021 (USD MILLION)
    • TABLE 270 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022-2027 (USD MILLION)
    • TABLE 271 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2021 (USD MILLION)
    • TABLE 272 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022-2027 (USD MILLION)
    • TABLE 273 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2021 (USD MILLION)
    • TABLE 274 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022-2027 (USD MILLION)
    • TABLE 275 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2021 (USD MILLION)
    • TABLE 276 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022-2027 (USD MILLION)
  • 12.7 MIDDLE EAST & AFRICA
    • 12.7.1 INCREASING R&D INVESTMENTS AND FOCUS ON DEVELOPMENT OF NEW DRUGS ARE CONTRIBUTING TO MARKET GROWTH
    • TABLE 277 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019-2021 (USD MILLION)
    • TABLE 278 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022-2027 (USD MILLION)
    • TABLE 279 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019-2021 (USD MILLION)
    • TABLE 280 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 281 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019-2021 (USD MILLION)
    • TABLE 282 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022-2027 (USD MILLION)
    • TABLE 283 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019-2021 (USD MILLION)
    • TABLE 284 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022-2027 (USD MILLION)
    • TABLE 285 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019-2021 (USD MILLION)
    • TABLE 286 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022-2027 (USD MILLION)
    • TABLE 287 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019-2021 (USD MILLION)
    • TABLE 288 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022-2027 (USD MILLION)

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • FIGURE 31 KEY DEVELOPMENTS IN IN VITRO TOXICOLOGY TESTING MARKET, 2019-2022
  • 13.3 MARKET SHARE ANALYSIS
    • FIGURE 32 IN VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2021
    • TABLE 289 IN VITRO TOXICOLOGY TESTING MARKET: DEGREE OF COMPETITION
  • 13.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
  • 13.5 COMPANY EVALUATION QUADRANT
    • 13.5.1 STAR
    • 13.5.2 EMERGING LEADER
    • 13.5.3 PERVASIVE
    • 13.5.4 PARTICIPANT
    • FIGURE 34 IN VITRO TOXICOLOGY TESTING MARKET: COMPANY EVALUATION QUADRANT, 2021
  • 13.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
    • 13.6.1 PROGRESSIVE COMPANY
    • 13.6.2 STARTING BLOCK
    • 13.6.3 RESPONSIVE COMPANY
    • 13.6.4 DYNAMIC COMPANY
    • FIGURE 35 IN VITRO TOXICITY MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021
  • 13.7 COMPANY FOOTPRINT ANALYSIS
    • 13.7.1 COMPANY PRODUCT FOOTPRINT
    • TABLE 290 COMPANY PRODUCT FOOTPRINT: IN VITRO TOXICOLOGY TESTING MARKET (2021)
  • 13.8 COMPANY REGIONAL FOOTPRINT
    • TABLE 291 COMPANY REGIONAL FOOTPRINT: IN VITRO TOXICOLOGY TESTING MARKET (2021)
  • 13.9 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
    • TABLE 292 IN VITRO TOXICOLOGY TESTING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
    • TABLE 293 IN VITRO TOXICOLOGY TESTING MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
  • 13.10 COMPETITIVE SCENARIO
    • TABLE 294 PRODUCT LAUNCHES
    • TABLE 295 DEALS
    • TABLE 296 OTHER DEVELOPMENTS

14 COMPANY PROFILES

  • 14.1 MAJOR PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 14.1.1 THERMO FISHER SCIENTIFIC, INC.
    • TABLE 297 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
    • FIGURE 36 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
    • 14.1.2 MERCK KGAA
    • TABLE 298 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 37 MERCK KGAA: COMPANY SNAPSHOT (2021)
    • 14.1.3 EUROFINS SCIENTIFIC SE
    • TABLE 299 EUROFINS SCIENTIFIC SE: BUSINESS OVERVIEW
    • FIGURE 38 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021)
    • 14.1.4 GENERAL ELECTRIC COMPANY
    • TABLE 300 GENERAL ELECTRIC COMPANY: BUSINESS OVERVIEW
    • FIGURE 39 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2021)
    • 14.1.5 LABORATORY CORPORATION OF AMERICA HOLDINGS
    • TABLE 301 LABORATORY CORPORATION OF AMERICA HOLDINGS: BUSINESS OVERVIEW
    • FIGURE 40 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2021)
    • 14.1.6 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
    • TABLE 302 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: BUSINESS OVERVIEW
    • FIGURE 41 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2021)
    • 14.1.7 SGS SA
    • TABLE 303 SGS SA: BUSINESS OVERVIEW
    • FIGURE 42 SGS SA: COMPANY SNAPSHOT (2021)
    • 14.1.8 BIO-RAD LABORATORIES, INC.
    • TABLE 304 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 43 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
    • 14.1.9 QIAGEN
    • TABLE 305 QIAGEN: BUSINESS OVERVIEW
    • FIGURE 44 QIAGEN: COMPANY SNAPSHOT (2021)
    • 14.1.10 EVOTEC AG
    • TABLE 306 EVOTEC AG: BUSINESS OVERVIEW
    • FIGURE 45 EVOTEC AG: COMPANY SNAPSHOT (2021)
    • 14.1.11 PROMEGA CORPORATION
    • TABLE 307 PROMEGA CORPORATION.: BUSINESS OVERVIEW
    • 14.1.12 CATALENT, INC.
    • TABLE 308 CATALENT, INC.: BUSINESS OVERVIEW
    • FIGURE 46 CATALENT, INC.: COMPANY SNAPSHOT (2021)
  • 14.2 OTHER COMPANIES
    • 14.2.1 GENTRONIX LIMITED
    • TABLE 309 GENTRONIX LIMITED: COMPANY OVERVIEW
    • 14.2.2 MB RESEARCH LABORATORIES
    • TABLE 310 MB RESEARCH LABORATORIES: COMPANY OVERVIEW
    • 14.2.3 BIOIVT
    • TABLE 311 BIOIVT: COMPANY OVERVIEW
    • 14.2.4 CREATIVE BIOLABS
    • TABLE 312 CREATIVE BIOLABS: COMPANY OVERVIEW
    • 14.2.5 GVK BIOSCIENCES PRIVATE LIMITED
    • TABLE 313 GVK BIOSCIENCES PRIVATE LIMITED: COMPANY OVERVIEW
    • 14.2.6 SHANGHAI MEDICILON INC.
    • TABLE 314 SHANGHAI MEDICILON INC.: COMPANY OVERVIEW
    • 14.2.7 CREATIVE BIOARRAY
    • TABLE 315 CREATIVE BIOARRAY: COMPANY OVERVIEW
    • 14.2.8 INSPHERO
    • TABLE 316 INSPHERO: COMPANY OVERVIEW
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

15 RELATED MARKETS

  • 15.1 INTRODUCTION
  • 15.2 IN VIVO TOXICITY MARKET
    • 15.2.1 MARKET DEFINITION
    • 15.2.2 LIMITATIONS
    • 15.2.3 MARKET OVERVIEW
    • FIGURE 47 CONSUMABLES SEGMENT WILL CONTINUE TO DOMINATE THE IN VIVO TOXICOLOGY MARKET DURING THE FORECAST PERIOD
  • 15.3 IN VIVO TOXICOLOGY MARKET, BY PRODUCT
    • 15.3.1 CONSUMABLES
    • TABLE 317 IN VIVO TOXICITY CONSUMABLES MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
    • 15.3.2 INSTRUMENTS
    • TABLE 318 IN VIVO TOXICOLOGY INSTRUMENTS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • 15.4 IN VIVO TOXICITY MARKET, BY TOXICITY ENDPOINT
    • 15.4.1 IMMUNOTOXICITY
    • TABLE 319 IN VIVO TOXICOLOGY MARKET FOR IMMUNOTOXICITY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
    • 15.4.2 SYSTEMIC TOXICITY
    • TABLE 320 IN VIVO TOXICOLOGY MARKET FOR SYSTEMIC TOXICITY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
    • 15.4.3 CARCINOGENICITY
    • TABLE 321 IN VIVO TOXICOLOGY MARKET FOR CARCINOGENICITY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
    • 15.4.4 GENOTOXICITY
    • TABLE 322 IN VIVO TOXICOLOGY MARKET FOR GENOTOXICITY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
    • 15.4.5 DEVELOPMENTAL AND REPRODUCTIVE TOXICITY (DART)
    • TABLE 323 IN VIVO TOXICOLOGY MARKET FOR DEVELOPMENTAL AND REPRODUCTIVE TOXICITY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
    • 15.4.6 OTHER TOXICITY ENDPOINTS
    • TABLE 324 IN VIVO TOXICOLOGY MARKET FOR OTHER TOXICITY ENDPOINTS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • 15.5 IN VIVO TOXICITY MARKET, BY REGION
    • 15.5.1 NORTH AMERICA
    • TABLE 325 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET, BY TOXICOLOGY ENDPOINT, 2015-2022 (USD MILLION)
    • 15.5.2 EUROPE
    • TABLE 326 EUROPE: IN VIVO TOXICOLOGY MARKET, BY TOXICOLOGY ENDPOINT, 2015-2022 (USD MILLION)
    • 15.5.3 ASIA PACIFICASIA PACIFIC
    • TABLE 327 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET, BY TOXICOLOGY ENDPOINT, 2015-2022 (USD MILLION)
    • 15.5.4 LATIN AMERICA
    • TABLE 328 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET, BY TOXICOLOGY ENDPOINT, 2015-2022 (USD MILLION)
    • 15.5.5 MIDDLE EAST & AFRICA
    • TABLE 329 MIDDLE EAST & AFRICA: IN VIVO TOXICOLOGY MARKET, BY TOXICOLOGY ENDPOINT, 2015-2022 (USD MILLION)

16 APPENDIX

  • 16.1 INSIGHTS OF INDUSTRY EXPERTS
  • 16.2 DISCUSSION GUIDE
  • 16.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.4 AVAILABLE CUSTOMIZATIONS
  • 16.5 RELATED REPORTS
  • 16.6 AUTHOR DETAILS